AAAAAA

   
Results: 1-9 |
Results: 9
Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg
Authors: Heijtink, RA van Bergen, P van Roosmalen, MH Sunnen, CMG Paulij, WP Schalm, SW Osterhaus, ADME
Citation: Ra. Heijtink et al., Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg, VACCINE, 19(27), 2001, pp. 3671-3680
Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: Monitoring of serum TUVIRUMAB in immune complexes
Authors: Heijtink, RA van Nunen, AB van Bergen, P Ostberg, L Osterhaus, ADME de Man, RA
Citation: Ra. Heijtink et al., Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: Monitoring of serum TUVIRUMAB in immune complexes, J MED VIROL, 64(4), 2001, pp. 427-434
Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication
Authors: Heijtink, RA Janssen, HLA Hop, WCJ Osterhaus, ADME Schalm, SW
Citation: Ra. Heijtink et al., Interferon-alpha therapy for chronic hepatitis B: Early response related to pre-treatment changes in viral replication, J MED VIROL, 63(3), 2001, pp. 217-219
Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy
Authors: Heijtink, RA Janssen, HLA Hop, WCJ Osterhaus, ADME Schalm, SW
Citation: Ra. Heijtink et al., Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy, J VIRAL HEP, 7(5), 2000, pp. 382-386
Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines
Authors: Heijtink, RA van Bergen, P Paulij, WP de Man, RA Osterhaus, ADME
Citation: Ra. Heijtink et al., Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines, VACCINE, 18(15), 2000, pp. 1531-1538
Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients
Authors: van Nunen, AB de Man, RA Heijtink, RA Niesters, HGM Schalm, SW
Citation: Ab. Van Nunen et al., Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients, J HEPATOL, 32(6), 2000, pp. 1040-1041
Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment
Authors: Janssen, HLA Gerken, G Carreno, V Marcellin, P Naoumov, NV Craxi, A Ring-Larsen, H Kitis, G van Hattum, J de Vries, RA Michielsen, PP ten Kate, FJW Hop, WCJ Heijtink, RA Honkoop, P Schalm, SW
Citation: Hla. Janssen et al., Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment, HEPATOLOGY, 30(1), 1999, pp. 238-243
Characteristics of the early phase of chronicity in acute hepatitis B infection
Authors: Heijtink, RA Paulij, W van Roosmalen, M Hellings, JA Niesters, HGM Schalm, SW Osterhaus, ADME
Citation: Ra. Heijtink et al., Characteristics of the early phase of chronicity in acute hepatitis B infection, J MED VIROL, 57(4), 1999, pp. 331-336
Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen
Authors: Paulij, WP de Wit, PLM Sunnen, CMG van Roosmalen, MH Petersen-van Ettekoven, A Cooreman, MP Heijtink, RA
Citation: Wp. Paulij et al., Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen, J GEN VIROL, 80, 1999, pp. 2121-2126
Risultati: 1-9 |